Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

Original Article

J.D. Chalmers, P.-R. Burgel, C.L. Daley, A.D. Soyza, C.S. Haworth, D. Mauger, M.R. Loebinger, P.J. McShane, F.C. Ringshausen, F. Blasi, M. Shteinberg, K. Mange, A. Teper, C. Fernandez, M. Zambrano, C. Fan, X. Zhang, and M.L. Metersky

N Engl J Med 2025;392:1569-1581

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
04/23/2025
Course expires: 
04/24/2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.